Telvate-MT Tablet ER
Marketer
Adivis Pharma Pvt Ltd
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (47.5mg)
Overview Telvate-MT Tablet ER
CardioTen ER tablets are prescribed for hypertension management. This medication reduces blood pressure, thereby mitigating the risk of future strokes and heart attacks. Early intervention significantly improves survival rates following a heart attack. For optimal blood levels, take CardioTen ER with meals at the same time daily, continuing as directed by your physician. Even feeling well, do not discontinue this medication independently, as hypertension is often asymptomatic; cessation may worsen your condition. Lifestyle modifications, including regular exercise, weight management, and a healthy diet, are also crucial for blood pressure control. Adhere strictly to your doctor's instructions. Common side effects include headache, weakness, dizziness, hypotension (occasionally with fainting), elevated potassium levels, shortness of breath, nausea, vomiting, abdominal pain, and fatigue. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from a seated position. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolyte levels may be required. Inform your doctor of any pre-existing liver or kidney conditions before starting treatment. Pregnant or breastfeeding individuals should seek medical advice before use. Disclose all other medications, particularly those for hypertension or heart conditions.
Uses of Telvate-MT Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Telvate-MT Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume Telvate-MT Extended-Release Tablets with food.
Common Side effects of Telvate-MT Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Telvate-MT Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Telvate-MT Tablet ER whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.
How Telvate-MT Tablet ER works:
Telmisartan and Metoprolol Succinate, combined in Telvate-MT Extended-Release Tablets, offer a dual approach to blood pressure management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telvate-MT Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Telvate-MT tablets pose a confirmed risk to a fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known dangers. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Telvate-MT tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Telvate-MT tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Telvate-MT Tablet ER without requiring any alteration to the prescribed dosage.
LiverCAUTION
Extended-release Telvate-MT tablets require careful administration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Telvate-MT Tablet ER :
Should you forget a Telvate-MT Tablet ER dose, administer it immediately if convenient. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telvate-MT Tablet ER
| Label | Value |
|---|---|
| Addictive | None. |
| Type of Medication | HEART |


